A Study of SI-6603 in Patients With Lumbar Disc Herniation

Status:
Completed

Trial end date:
2018-02-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the safety and efficacy of SI-6603(Condoliase) in patients with lumbar disc herniation.

Phase 3

Seikagaku Corporation